Get the Stockscreener App
0.4657
2.37%
-0.0113
After Hours:
.46
-0.0057
-1.22%
Harvard Bioscience Inc stock is traded at $0.4657, with a volume of 424.69K.
It is down -2.37% in the last 24 hours and up +4.93% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.477
Open:
$0.4724
24h Volume:
424.69K
Relative Volume:
0.04
Market Cap:
$20.59M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-2.3285
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
-18.30%
1M Performance:
+4.93%
6M Performance:
-72.77%
1Y Performance:
-85.45%
1-Day Range:
$0.4602
$0.4794
1-Week Range:
$0.4602
$0.58
52-Week Range:
$0.2813
$3.27
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.4657 | 21.09M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
What institutional investors are buying Harvard Bioscience Inc. stockRetirement Planning Report With Low Risk - jammulinksnews.com
Combining machine learning predictions for Harvard Bioscience Inc.Technical Reversal Setup with Risk Limits - Newser
Why Harvard Bioscience Inc. stock attracts strong analyst attentionAnnual Market Behavior and Sector Summary - Newser
What makes Harvard Bioscience Inc. stock price move sharplyTrade Setup Builder with Custom Alerts - Newser
Published on: 2025-07-29 20:00:42 - metal.it
Earnings Chart Overlay Points to Harvard Bioscience Inc. UpsideEarly Entry Picks Before News Breakout Reviewed - metal.it
What are analysts’ price targets for Harvard Bioscience Inc. in the next 12 monthsChart Pattern Updates With High Returns - jammulinksnews.com
What is the risk reward ratio of investing in Harvard Bioscience Inc. stockAchieve rapid financial growth with expert help - jammulinksnews.com
Detecting support and resistance levels for Harvard Bioscience Inc.Forecasting Stock Moves with AI Insights - Newser
Is Harvard Bioscience Inc. stock overvalued or undervaluedAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
Is Harvard Bioscience Inc. a growth stock or a value stockGet alerts on the hottest market movers - jammulinksnews.com
Detecting support and resistance levels for Harvard Bioscience Inc. Watchlist Summary for Active Day Traders - Newser
What are the latest earnings results for Harvard Bioscience Inc.Track top-performing stocks effortlessly - jammulinksnews.com
What are Harvard Bioscience Inc. company’s key revenue driversExponential return rates - jammulinksnews.com
What is Harvard Bioscience Inc. company’s growth strategyDiscover undervalued opportunities early - jammulinksnews.com
How does Harvard Bioscience Inc. compare to its industry peersMaximize your returns with smart trade entries - jammulinksnews.com
When is Harvard Bioscience Inc. stock expected to show significant growthFree Investment Community - jammulinksnews.com
How Efficient Is Harvard Bioscience Inc. at Controlling Operating CostsWeekly Double Return List - Newser
Is Harvard Bioscience Inc. Stock a Good Fit for Conservative InvestorsProven Return Strategy Execution - Newser
What analysts say about Harvard Bioscience Inc. stockMarket-leading growth rates - Autocar Professional
What makes Harvard Bioscience Inc. stock attractive to long term investorsRecord-setting profit potential - jammulinksnews.com
What drives Harvard Bioscience Inc. stock priceHigh-performance investment picks - Autocar Professional
Harvard Bioscience Skyrockets 24.45%—Is This a Penny Stock Play or a Sector Catalyst? - AInvest
Does Harvard Bioscience (NASDAQ:HBIO) Have A Healthy Balance Sheet? - simplywall.st
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):